Skip to content
zameds

Tadalafil (Tadalafil Cipla, Caverfil)

Tadalafil

Cipla Medpro (Pty) Ltd

S4

Registration

Applicant
Cipla Medpro (Pty) Ltd
Certificate holder
Cipla Medpro (Pty) Ltd
Registrations
4
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Tadalafil 5 cipla

Each tablet contains TADALAFIL 5,0 mg

5Film-coated tablets51003251/7.1.5/0032Approved 16 January 2026RegisteredS4PIPIL
Tadalafil 20 cipla

Each tablet contains TADALAFIL 20,0 mg

20Film-coated tablets51003351/7.1.5/0033Approved 16 January 2026RegisteredS4PIPIL
Caverfil 5

Each tablet contains TADALAFIL 5,0 mg

5 mg/ 20 mgFilm-coated tablets510034.03251/7.1.5/0034.032Approved 16 January 2026RegisteredS4PIPIL
Caverfil 20

Each tablet contains TADALAFIL 20,0 mg

5 mg/ 20 mgFilm-coated tablets510035.03351/7.1.5/0035.033Approved 16 January 2026RegisteredS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Tadalafil

  • S4: Tadalafil

    Consolidated Schedules 06 July 2026, line 8086

Pharmacological class: Vasodilators - peripheral. (class 7.1.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C22H19N3O4389.40 g/mol

(2R,8R)-2-(1,3-Benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione

Drag to rotate. Structure from PubChem CID 110635.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles